2024-06-13 | Sale | Kymera Therapeutics, Inc. KYMR | director | 10,200 0.0168% | $34.98 | $356,796 | -9.81% | |
2024-06-12 | Sale | Kymera Therapeutics, Inc. KYMR | director | 16,740 0.028% | $35.45 | $593,378 | -8.57% | |
2024-03-15 | Sale | Kymera Therapeutics, Inc. KYMR | director | 71,764 0.1171% | $40.46 | $2.9M | -13.23% | |
2024-03-14 | Sale | Kymera Therapeutics, Inc. KYMR | director | 55,779 0.0861% | $39.98 | $2.23M | -10.78% | |
2024-03-13 | Sale | Kymera Therapeutics, Inc. KYMR | director | 139,255 0.2271% | $42.23 | $5.88M | -16.65% | |
2024-03-12 | Sale | Kymera Therapeutics, Inc. KYMR | director | 162,918 0.2674% | $41.98 | $6.84M | -15.72% | |
2024-03-11 | Sale | Kymera Therapeutics, Inc. KYMR | director | 51,184 0.0849% | $42.85 | $2.19M | -16.61% | |
2023-01-12 | Sale | Kymera Therapeutics, Inc. KYMR | director | 98,720 0.153% | $30.29 | $2.99M | -26.07% | |
2023-01-11 | Sale | Kymera Therapeutics, Inc. KYMR | director | 27,754 0.0478% | $29.96 | $831,510 | -16.97% | |
2022-12-15 | Sale | Kymera Therapeutics, Inc. KYMR | director | 3,278 0.0061% | $30.00 | $98,340 | -11.97% | |
2022-12-14 | Sale | Kymera Therapeutics, Inc. KYMR | director | 378,966 0.6933% | $31.37 | $11.89M | -17.08% | |
2022-11-03 | Sale | Kymera Therapeutics, Inc. KYMR | director | 96,397 0.1616% | $30.00 | $2.89M | -11% | |
2022-11-02 | Sale | Kymera Therapeutics, Inc. KYMR | director | 123,619 0.223% | $30.02 | $3.71M | -4.24% | |
2022-11-01 | Sale | Kymera Therapeutics, Inc. KYMR | director | 77,030 0.136% | $30.60 | $2.36M | -7.8% | |
2022-10-31 | Sale | Kymera Therapeutics, Inc. KYMR | director | 120,622 0.2076% | $30.23 | $3.65M | -8.7% | |
2022-10-28 | Sale | Kymera Therapeutics, Inc. KYMR | director | 91,050 0.1573% | $30.00 | $2.73M | -7.5% | |
2022-01-11 | Vigil Neuroscience, Inc. VIGL | director | 535,000 2.3688% | $14.00 | $7.49M | -24.96% | ||
2021-08-11 | Sale | Kymera Therapeutics, Inc. KYMR | director | 484,266 1.0271% | $61.00 | $29.54M | -27.25% | |
2021-03-12 | Sale | Kymera Therapeutics, Inc. KYMR | director | 458,700 1.0347% | $56.50 | $25.92M | -6.59% | |
2018-02-13 | Viridian Therapeutics, Inc. VRDN | director | 1.09M 4.1192% | $5.50 | $6M | +6.91% |